Please assess the completion status of the following clinical trial:

Trial Title: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Must have been treated with hESC-RPE cell transplant in the core protocol.~* Able to understand and willing to sign the informed consent to participate in the follow-up study.~Exclusion Criteria:~* There are no exclusion criteria

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental: MA09-hRPE (Type: None): Sub-retinal transplantation of MA09-hRPE cells

Based on this trial design, predict the completion outcome and termination type (if applicable).